Tome Biosciences Funding & Investors
Tome Biosciences is a biotechnology company that develops programmable gene insertion technology. Using CRISPR, its technologies allow them to insert any genetic sequence of any size at any location into any genome.
tome.bioTotal Amount Raised: $213,000,000
Tome Biosciences Funding Rounds
Series A
$213,000,000
Series A Investors
Longwood FundGVBrukerArch Venture PartnersAndreessen HorowitzFUJIFILMPolaris PartnersAlexandria Venture Investments
Funding info provided by Diffbot.